Sean P. Nolan Taysha Gene Therapies, Inc. (TSHA) insider trading activity

TSHA Quotes by TradingView

Sean P. Nolan is Chief Executive Officer of Taysha Gene Therapies, Inc.. Currently has a direct ownership of 2.08 Million shares of TSHA, which is worth approximately $3.99 Million. The most recent transaction as insider was on Jan 02, 2025, when has been sold 892,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.08M
75.26% 3M change
75.26% 12M change
Total Value Held $3.99 Million

Sean P. Nolan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2025
BUY
Grant, award, or other acquisition
-
892,500 Added 30.04%
2,078,358 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
1,184,688 Added 49.98%
1,185,858 Common Stock
May 20 2021
BUY
Open market or private purchase
$26,150 $22.35 p/Share
1,170 Added 50.0%
1,170 Common Stock

Also insider at

VTR
Ventas, Inc. Real Estate
Director
SPN

Sean P. Nolan

Chief Executive Officer
Chicago, IL

Track Institutional and Insider Activities on TSHA

Follow Taysha Gene Therapies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TSHA shares.

Notify only if

Insider Trading

Get notified when an Taysha Gene Therapies, Inc. insider buys or sells TSHA shares.

Notify only if

News

Receive news related to Taysha Gene Therapies, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TSHA